Coloplast AS (COLO B)-Financial and Strategic SWOT Analysis Review

Coloplast AS (COLO B)-Financial and Strategic SWOT Analysis Review

  • Products Id :- GDME529FSA
  • |
  • Pages: 49
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Coloplast AS (COLO B)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Coloplast A/S (Coloplast) is a medical device company that offers products and services for ostomy care, urology care, continence care, and skin and wound care. Its major products include ostomy bags; urisheaths; urine bags; catheters; anal irrigation systems; vaginal sling products; dressings for infected, non-infected and painful wounds; cleansers; moisturizers; skin protectants; anti-fungals; and hand cleansers. It also offers a wide range of disposable products to support endourologic and percutaneous procedures, prostate disorders, laparoscopic procedures, and testicular prosthesis. Coloplast supplies its products through subsidiaries and distributors to hospitals, institutions, wholesalers and retailers in Europe, Asia-Pacific and North America. Coloplast is headquartered in Humlebaek, Denmark.

Coloplast AS Key Recent Developments

Aug 16,2017: Coloplast delivers satisfactory Q3 result

May 03,2017: Coloplast delivers satisfactory Q2 result

Apr 03,2017: Coloplast wins Red Dot design award for high quality design

Apr 03,2017: Coloplast

Feb 02,2017: Coloplast delivers Satisfactory Q1 Interim Results in Line with Guidance

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Coloplast A/S-Key Facts 6

Coloplast A/S-Key Employees 7

Coloplast A/S-Key Employee Biographies 8

Coloplast A/S-Major Products and Services 9

Coloplast A/S-History 12

Coloplast A/S-Company Statement 13

Coloplast A/S-Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Section 2-Company Analysis 18

Coloplast A/S-Business Description 18

Business Description-Continence Care 18

Continence Care-Overview 18

Business Description-Ostomy Care 18

Ostomy Care-Overview 18

Business Description-Urology Care 18

Urology Care-Overview 18

Business Description-Wound and Skin Care 19

Wound and Skin Care-Overview 19

Coloplast A/S-Corporate Strategy 20

Coloplast A/S-SWOT Analysis 21

SWOT Analysis-Overview 21

Coloplast A/S-Strengths 21

Coloplast A/S-Weaknesses 22

Coloplast A/S-Opportunities 23

Coloplast A/S-Threats 24

Coloplast A/S-Key Competitors 25

Section 3-Company Financial Ratios 26

Financial Ratios-Capital Market Ratios 26

Financial Ratios-Annual Ratios 27

Performance Chart 30

Financial Performance 30

Financial Ratios-Interim Ratios 31

Financial Ratios-Ratio Charts 32

Section 4-Company's Lifesciences Financial Deals and Alliances 33

Coloplast A/S, Medical Equipment, Deals By Year, 2011 to YTD 2017 33

Coloplast A/S, Medical Equipment, Deals By Type, 2011 to YTD 2017 34

Coloplast A/S, Recent Deals Summary 35

Section 5-Company's Recent Developments 36

May 03, 2017: Coloplast delivers satisfactory Q2 result 36

Apr 03, 2017: Coloplast wins Red Dot design award for high quality design 37

Feb 02, 2017: Coloplast delivers Satisfactory Q1 Interim Results in Line with Guidance 38

Nov 02, 2016: Coloplast delivers full-year results in line with guidance 39

Sep 26, 2016: Coloplast introduces new silicone wound dressings as part of growth ambition 40

Aug 16, 2016: Coloplast delivers 9M result in line with guidance 41

May 03, 2016: Coloplast delivers H1 result in line with expectations 42

Mar 09, 2016: Coloplast gets breakthrough with continence business in Japan 43

Feb 02, 2016: Coloplast delivers Q1 results in line with guidance 44

Section 6-Appendix 45

Methodology 45

Ratio Definitions 45

About GlobalData 49

Contact Us 49

Disclaimer 49

List of Figures

Coloplast A/S, Performance Chart (2012-2016) 30

Coloplast A/S, Ratio Charts 32

Coloplast A/S, Medical Equipment, Deals By Year, 2011 to YTD 2017 33

Coloplast A/S, Medical Equipment, Deals by Type, 2011 to YTD 2017 34

List of Tables

Coloplast A/S, Key Facts 6

Coloplast A/S, Key Employees 7

Coloplast A/S, Key Employee Biographies 8

Coloplast A/S, Major Products and Services 9

Coloplast A/S, History 12

Coloplast A/S, Other Locations 15

Coloplast A/S, Subsidiaries 15

Coloplast A/S, Key Competitors 25

Coloplast A/S, Ratios based on current share price 26

Coloplast A/S, Annual Ratios 27

Coloplast A/S, Annual Ratios (Cont...1) 28

Coloplast A/S, Annual Ratios (Cont...2) 29

Coloplast A/S, Interim Ratios 31

Coloplast A/S, Medical Equipment, Deals By Year, 2011 to YTD 2017 33

Coloplast A/S, Medical Equipment, Deals By Type, 2011 to YTD 2017 34

Coloplast A/S, Recent Deals Summary 35

Currency Codes 45

Capital Market Ratios 45

Equity Ratios 46

Profitability Ratios 46

Cost Ratios 47

Liquidity Ratios 47

Leverage Ratios 48

Efficiency Ratios 48

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Coloplast AS, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8903
Site License
USD 250 INR 17805
Corporate User License
USD 375 INR 26708



We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]